USFDA & biotechHigh importanceAug 26 · 21:15 KST
We show only the direction of market expectations, not consensus figures. For reference only; not investment advice.
Swoop® System Sequences FDA review: a US FDA-related date, scheduled for Aug 26, 2026 at 21:15 KST. The review outcome and details are confirmed by the company’s official announcements and FDA notices.
FDA dates for biotech companies (approval reviews, advisory committees and so on) tend to be followed by larger moves in the related shares, depending on the outcome. This page provides schedule facts for reference only; it is not a prediction.
Swoop® System Sequences FDA review: a US FDA review or announcement date. It is scheduled for Aug 26, 2026.
In the company’s official announcements (press releases, SEC filings) and FDA notices.
Approval and review outcomes can change how the company’s business is assessed, so related shares tend to be more volatile around the announcement (for reference only; not a prediction).
